Etira founder Dr. Ratna Vadlamudi honored with the prestigious 2023 Distinguished Research Scholar Award
Dallas, Texas. April 17, 2023:
We are excited to congratulate one of our founders, Dr. Ratna Vadlamudi, Professor and Vice Chair for Research, Division of Reproductive Research, Department of Obstetrics & Gynecology, Long School of Medicine, who received the prestigious 2023 Presidential Distinguished Research Scholar Award. The Presidential Awards ceremony, held April 17 at the Betty Kelso Center at the San Antonio Botanical Gardens, recognized 15 individuals with awards given in the areas of distinguished research scholar, clinical excellence, teaching excellence (emerging and sustained), and employee excellence.
Established in 1985, the Presidential Awards recognize exemplary performance by individuals who consistently excel in their positions and demonstrate a strong commitment to the mission and core values of UT Health San Antonio. The annual awards provide the university the opportunity to recognize outstanding faculty, staff, and team contributions. The award recipients received a plaque, a monetary gift, and a congratulatory Senate Proclamation from the State of Texas by Senator José Menéndez.
Congratulations Dr. Vadlamudi! A well-deserved honor
For additional photos, printed program, and video from the ceremony, please follow the links below.
https://news.uthscsa.edu/2023-presidential-awards-recipients-recognized-at-ceremony/
http://news.uthscsa.edu/wp-content/uploads/2023/04/Smaller-version.pdf
About Etira
EtiraRx is a privately owned Dallas-based biotech startup focused on developing the next generation of cancer therapies. EtiraRx is advancing their first small molecule drug, ERX-315, to phase I clinical trials later this year for patients with metastatic breast cancer.
Learn more at www.etira.life
contact@etirarx.com
